Anxiolytic compositions containing α
The invention relates to pharmaceutical compositions and food products containing peptides derived from the α s1 -casein in milk and having benzodiazepine-type activity and particularly, anxiolytic activity.
1. A method of treating anxiety, sleep disorders and epilepsy comprising administering a composition comprising an effective amount of at least one peptide consisting of the sequence SEQ ID No: 1 or SEQ ID No: 2.
2. A method of treating anxiety, sleep disorders and epilepsy comprising administering a composition comprising a hydrolysate of casein α s1 -casein and/or a fraction of a hydrolysate of casein or α s1 -casein, containing an effective amount of at least one peptide consisting of the sequence SEQ ID No: 1 or SEQ ID No: 2.
3. The method of claim 1 , wherein the method treats anxiety.
4. The method of claim 1 , wherein the method treats sleep disorders.
5. The method of claim 1 , wherein the method treats epilepsy.
6. The method of claim 1 , wherein the peptide is produced by a recombinant organism.
7. The method of claim 6 , wherein the recombinant organism is selected from the group consisting of bacteria, yeast and a mammalian cell.
8. The method of claim 2 , wherein the method treats anxiety.
9. The method of claim 2 , wherein the method treats sleep disorders.
10. The method of claim 2 , wherein the method treats epilepsy.
11. The method of claim 2 , wherein the peptide is produced by a recombinant organism.
12. The method of claim 11 , wherein the recombinant organism is selected from the group consisting of bacteria, yeast and a mammalian cell.